Ignite Creation Date:
2024-10-25 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06537518
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
The Difference Between Using Local and General Dexamethasone in Arthroscopic Anterior Cruciate Ligament Repair
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Adductor Canal Block With Dexamethasone Versus Adductor Canal Block With Systemic Dexamethasone in Arthroscopic Anterior Cruciate Ligament Repair
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Arthroscopic knee injuries such as the anterior cruciate ligament ACL injury are common and often result in postoperative pain Regional anesthetic techniques such as femoral nerve block FNB and adductor canal block ACB can help alleviate pain and reduce opioid consumption ACB which blocks the saphenous nerve and obturator nerve branches is preferred over FNB due to its potential to decrease mobility and increase falls risk Dexamethasone a potent glucocorticoid is used as an adjuvant for ACB but its perineural administration may carry neurotoxicity risks Some pain physicians prefer intravenous administration to prolong the action of local anesthetics used in peripheral nerve blocks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None